APA (7th ed.) Citation

Parta, M., & Musher, D. M. (2011). Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus aureus Bacteremia. Clinical Infectious Diseases, 52(8), 1079. https://doi.org/10.1093/cid/cir088

Chicago Style (17th ed.) Citation

Parta, Mark, and Daniel M. Musher. "Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus Aureus Bacteremia." Clinical Infectious Diseases 52, no. 8 (2011): 1079. https://doi.org/10.1093/cid/cir088.

MLA (9th ed.) Citation

Parta, Mark, and Daniel M. Musher. "Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus Aureus Bacteremia." Clinical Infectious Diseases, vol. 52, no. 8, 2011, p. 1079, https://doi.org/10.1093/cid/cir088.